1. Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis 
K. Budding, E.A. van de Graaf, T. Hoefnagel, J.M. Kwakkel-van Erp, D.A. van Kessel, D. Dragun, C.E. Hack, H.G. Otten 
Journal of Cystic Fibrosis 
Volume 14, Issue 1, Pages (January 2015)
DOI: /j.jcf
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
ETAR and AT1R autoantibody titers pre-and post-lung transplantation.
Pre- (A and C) and post-transplantation (B and D) antibody levels against ETAR (A and B) and AT1R (C and D) are displayed in U/ml. Cut-off levels to define positivity were set according to previously described healthy control values (see Patients and methods). Each dot represents the result from 1 serum sample. No significant differences between CF and ILD were found between pre- and post-LTx anti-ETAR, p=0.31 and p=0.38, and pre- and post-LTx anti-AT1R autoantibodies, p=0.28 and p=0.58 respectively. A Mann–Whitney rank-sum test was used for statistical analysis (GraphPad Prism version 5.03, GraphPad Software Inc., San Diego, CA).
Journal of Cystic Fibrosis  , 42-45DOI: ( /j.jcf )
Copyright © 2014 European Cystic Fibrosis Society. Terms and Conditions